SFM
ALDX icon

Sphera Funds Management’s Aldeyra Therapeutics ALDX Stock Holding History

Sphera Funds Management’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-150,000
Closed -$1.7M – 118
2021
Q2 		$1.7M Buy
+150,000
New +$1.8M 0.12% 110
2020
Q2 		– Sell
-1,069,089
Closed -$2.64M – 89
2020
Q1 		$2.64M Hold
1,069,089
– – 0.33% 48
2019
Q4 		$6.21M Hold
1,069,089
– – 0.51% 43
2019
Q3 		$5.63M Hold
1,069,089
– – 0.87% 36
2019
Q2 		$6.42M Hold
1,069,089
– – 0.88% 34
2019
Q1 		$9.65M Sell
1,069,089
-163,000
-13% -$1.39M 0.88% 21
2018
Q4 		$10.2M Buy
1,232,089
+90,000
+8% +$922K 1.15% 22
2018
Q3 		$15.8M Buy
1,142,089
+295,154
+35% +$2.39M 1.81% 10
2018
Q2 		$6.73M Sell
846,935
-162,196
-16% -$1.29M 0.93% 27
2018
Q1 		$7.57M Sell
1,009,131
-35,000
-3% -$266K 1.15% 22
2017
Q4 		$7.1M Hold
1,044,131
– – 0.83% 26
2017
Q3 		$7.52M Buy
1,044,131
+168,200
+19% +$878K 1.07% 19
2017
Q2 		$4.12M Buy
875,931
+207,431
+31% +$954K 0.7% 41
2017
Q1 		$3.34M Buy
668,500
+300,000
+81% +$1.54M 0.65% 44
2016
Q4 		$1.97M Hold
368,500
– – 0.5% 58
2016
Q3 		$2.89M Hold
368,500
– – 0.47% 55
2016
Q2 		$2.1M Buy
368,500
+130,000
+55% +$726K 0.54% 57
2016
Q1 		$999K Hold
238,500
– – 0.22% 81
2015
Q4 		$1.62M Sell
238,500
-26,500
-10% -$178K 0.24% 95
2015
Q3 		$1.54M Hold
265,000
– – 0.2% 108
2015
Q2 		$2.06M Buy
265,000
+150,000
+130% +$1.29M 0.2% 110
2015
Q1 		$1.19M Buy
+115,000
New +$1.17M 0.12% 129

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM

Sphera Funds Management's ALDX Position: Q3 2021 in Review

Sphera Funds Management sold out of Aldeyra Therapeutics (ALDX) in Q3 2021, closing a stake of 150,000 shares — an estimated $1.7M sold.

Sphera Funds Management first reported a position in ALDX in Q1 2015 and held it in 22 quarters. The position peaked at $15.8M in Q3 2018. 117 funds tracked by Wall St. Rank hold ALDX as of Q3 2021.

  • Sphera Funds Management reported no remaining Aldeyra Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Sphera Funds Management sold 150,000 Aldeyra Therapeutics shares in Q3 2021, an estimated $1.7M.
  • Sphera Funds Management first reported a position in Aldeyra Therapeutics in Q1 2015 and held it in 22 quarters.
  • Sphera Funds Management's Aldeyra Therapeutics position peaked at $15.8M in Q3 2018.
  • 117 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2021.

Based on Sphera Funds Management's 13F filing for Q3 2021, filed 15 Nov 2021.